154 related articles for article (PubMed ID: 8116813)
1. In vitro activity of bisquinoline WR268,668 against African clones and isolates of Plasmodium falciparum.
Basco LK; Andersen SL; Milhous WK; Le Bras J; Vennerstrom JL
Am J Trop Med Hyg; 1994 Feb; 50(2):200-5. PubMed ID: 8116813
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum.
Basco LK; Le Bras J
Am J Trop Med Hyg; 1993 Jan; 48(1):120-5. PubMed ID: 8427380
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Basco LK; Le Bras J
Am J Trop Med Hyg; 1992 Oct; 47(4):521-7. PubMed ID: 1443351
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of pyronaridine against African strains of Plasmodium falciparum.
Basco LK; Le Bras J
Ann Trop Med Parasitol; 1992 Oct; 86(5):447-54. PubMed ID: 1288425
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.
Atteke C; Ndong JM; Aubouy A; Maciejewski L; Brocard J; Lébibi J; Deloron P
J Antimicrob Chemother; 2003 Apr; 51(4):1021-4. PubMed ID: 12654770
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.
Basco LK; Le Bras J
Am J Trop Med Hyg; 1993 Sep; 49(3):301-7. PubMed ID: 8372953
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Le Bras J
Am J Trop Med Hyg; 1995 Oct; 53(4):388-91. PubMed ID: 7485692
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Le Bras J
Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum.
Childs GE; Häusler B; Milhous W; Chen C; Wimonwattrawatee T; Pooyindee N; Boudreau EF
Am J Trop Med Hyg; 1988 Jan; 38(1):24-9. PubMed ID: 3277460
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine.
Pradines B; Mabika Mamfoumbi M; Parzy D; Owono Medang M; Lebeau C; Mourou Mbina JR; Doury JC; Kombila M
Am J Trop Med Hyg; 1999 Jan; 60(1):105-8. PubMed ID: 9988332
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
[TBL] [Abstract][Full Text] [Related]
12. Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria.
Vennerstrom JL; Ellis WY; Ager AL; Andersen SL; Gerena L; Milhous WK
J Med Chem; 1992 May; 35(11):2129-34. PubMed ID: 1597862
[TBL] [Abstract][Full Text] [Related]
13. [In vitro sensitivity of 85 Plasmodium falciparum isolates in the Fatick region, Senegal].
Pradines B; Rogier C; Fusai T; Tall A; Trape JF; Doury JC
Med Trop (Mars); 1996; 56(2):141-5. PubMed ID: 8926873
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents.
Pradines B; Tall A; Parzy D; Spiegel A; Fusai T; Hienne R; Trape JF; Doury JC
J Antimicrob Chemother; 1998 Sep; 42(3):333-9. PubMed ID: 9786473
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of mitochondrial ATP synthetase inhibitors against Plasmodium falciparum.
Basco LK; Le Bras J
J Eukaryot Microbiol; 1994; 41(3):179-83. PubMed ID: 8049680
[TBL] [Abstract][Full Text] [Related]
16. Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum.
Pradines B; Fusai T; Daries W; Laloge V; Rogier C; Millet P; Panconi E; Kombila M; Parzy D
J Antimicrob Chemother; 2001 Aug; 48(2):179-84. PubMed ID: 11481286
[TBL] [Abstract][Full Text] [Related]
17. Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.
Tahar R; Vivas L; Basco L; Thompson E; Ibrahim H; Boyer J; Nepveu F
J Antimicrob Chemother; 2011 Nov; 66(11):2566-72. PubMed ID: 21862474
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon.
Basco LK; Ringwald P
Antimicrob Agents Chemother; 2003 Apr; 47(4):1391-4. PubMed ID: 12654675
[TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu.
Le Bras J
Med Trop (Mars); 1998; 58(3 Suppl):18-21. PubMed ID: 10212892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
